To the editor, Carnitine palmitoyl transferase (CPT) 1A deficiency is a rare autosomal recessive condition deriving from a mutation in the CPT1A gene. Carnitine is found in nearly all cells of the body, and the CPT pathway has a crucial role in energy production through its enzyme and transporting functions. CPT1A (the hepatic isoform) is located on the outside of the mitochondrial membrane and is essential in transport of fatty acids to facilitate fatty acid oxidation. [1] A defect in the CPT1A pathway results in the inability to transport or break down longchain fatty acids.CPT1A deficiency commonly presents in children with symptoms of hypoketotic hypoglycemia, liver dysfunction, and encephalopathy during periods of fasting. The worldwide incidence is 1:500,000 to 1:1,000,000. Diagnosis is made by finding elevated total and free plasma carnitine levels and confirmed by a demonstrable mutation of the CPT1A gene or by means of enzyme activity in fibroblasts. [1] We describe a case of CPT1A deficiency presenting with acute-on-chronic liver failure (ACLF) in a previously well adult. It is believed to be the first reported case of an adult presentation requiring liver transplantation for hepatic failure due to CPT1A deficiency. Written informed consent was obtained from the patient prior to submission of this case report.